Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS

OBJECTIVE: To monitor the systemic immune responses of patients with multiple sclerosis (MS) under treatment with GNbAC1, a monoclonal antibody against the envelope protein of the MS- associated retrovirus, during a phase 2a trial. METHODS: We analyzed the composition of immune cell subsets and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmermann, Maria, Sanderson, Nicholas S.R., Rasenack, Maria, Lalive, Patrice H., Lang, Alois B., Curtin, Francois, Lindberg, Raija L.P., Kappos, Ludwig, Derfuss, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547879/
https://www.ncbi.nlm.nih.gov/pubmed/26380353
http://dx.doi.org/10.1212/NXI.0000000000000144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547879/
https://www.ncbi.nlm.nih.gov/pubmed/26380353
http://dx.doi.org/10.1212/NXI.0000000000000144

Ejemplares similares